Skip to content

13F-HR filed by Stonepine Capital Management, LLC

Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 29 holding rows worth $185,124,000.

Accession
0001567619-21-015505
Filed
2021-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, 29 entries on the cover page, a total value of $185,124,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $185,124,000 with VALUE read as thousands by filing date, 13F file number 028-17175. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY2,523,728$35,156,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM3,418,279$16,408,000thousands by filing date
CHIASMA INC16706W102COM4,940,273$15,463,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM2,450,193$12,349,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM422,310$10,849,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK2,483,059$9,982,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM3,293,419$9,584,000thousands by filing date
DIAMEDICA THERAPEUTICS INC25253X207COMMON STOCK1,023,409$9,364,000thousands by filing date
AFFIMED N VN01045108COM1,030,004$8,147,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM1,448,868$7,983,000thousands by filing date
XOMA ROYALTY CORPORATION98419J206COMMON STOCK163,266$6,663,000thousands by filing date
YUMANITY THERAPEUTICS INC98872L102COM335,745$6,077,000thousands by filing date
IVERIC BIO INC46583P102COM875,180$5,409,000thousands by filing date
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/2372942A107COMMON STOCK506,274$4,572,000thousands by filing date
CONFORMIS INC20717E101COM4,431,807$4,387,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock329,130$3,344,000thousands by filing date
EXAGEN INC30068X103COM191,006$3,343,000thousands by filing date
AYTU BIOPHARMA INC054754874COM362,910$2,758,000thousands by filing date
ANGION BIOMEDICA CORP03476J107COM134,984$2,439,000thousands by filing date
GAMIDA CELL LTDM47364100SHS244,515$1,978,000thousands by filing date
CELCUITY INC15102K100COM109,081$1,564,000thousands by filing date
CONTRAFECT CORP212326300COM269,101$1,292,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD445,701$1,230,000thousands by filing date
APTEVO THERAPEUTICS INC03835L207COMMON38,593$1,178,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM316,279$974,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM179,511$910,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR10,000$771,000thousands by filing date
BRAINSWAY LTD10501L106CMN55,181$498,000thousands by filing date
ONCOSEC MED INC68234L306COM94,783$452,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-21-015505this filing2021-08-13acceptance time not in the bulk data set
13F-HR/A 0001567619-21-015565 base2021-08-16acceptance time not in the bulk data set